Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Incarviatone A in drug for treating hemorrhagic fever with renal syndrome

A technology for renal syndrome and hemorrhagic fever, which can be applied to drug combinations, medical preparations containing active ingredients, and pharmaceutical formulations, etc., can solve problems such as uncertain effects, and achieve strong viral inhibitory activity and outstanding essence in hemorrhagic fever with renal syndrome. effects of sexuality

Inactive Publication Date: 2013-12-18
李浩福
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Antiviral treatments such as ribavirin and interferon are often used clinically, but the effect is not yet certain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Incarviatone A in drug for treating hemorrhagic fever with renal syndrome
  • Application of Incarviatone A in drug for treating hemorrhagic fever with renal syndrome
  • Application of Incarviatone A in drug for treating hemorrhagic fever with renal syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Embodiment 1: the preparation of compound Incarviatone A tablet involved in the present invention:

[0013] Take 20 grams of compound Incarviatone A, add 180 grams of conventional excipients for tablet preparation, mix well, and make 1000 tablets with a conventional tabletting machine.

Embodiment 2

[0014] Embodiment 2: the preparation of compound Incarviatone A capsules involved in the present invention:

[0015] Get 20 grams of compound Incarviatone A, add conventional excipients for preparing capsules such as 180 grams of starch, mix well, and pack into capsules to make 1000 tablets.

[0016] The following pharmacodynamic experiments will further illustrate its drug activity.

[0017] In order to better understand the essence of the present invention, the experimental results of Incarviatone A will be described below to illustrate its application in the field of pharmacy.

[0018] The specific experiment is as follows:

[0019] 1. Experimental study of Incarviatone A against hemorrhagic fever with renal syndrome virus

[0020] (1) In vitro inhibition experiment of hemorrhagic fever with renal syndrome virus

[0021] 1 material

[0022] (1) Virus strain: the international standard strain of hemorrhagic fever with renal syndrome virus 76-118, which is preserved by th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses novel application of Incarviatone A in preparation of a drug for treating hemorrhagic fever with renal syndrome. In-vitro and in-vivo inhibition experimental study on the effect of the Incarviatone A to hemorrhagic fever virus with renal syndrome shows that the Incarviatone A has low toxic effect on cells, has the direct killing effect on the hemorrhagic fever virus with renal syndrome, can obviously inhabit viral multiplication, has obvious protecting effect on susliks infected with the virus and enables the disease time to be postponed, the disease course to be prolonged and the death rate to be reduced. Therefore, the Incarviatone A is an effective and safe drug for treating the hemorrhagic fever with renal syndrome.

Description

technical field [0001] The present invention relates to the use of Incarviatone A, in particular to the use of Incarviatone A in the pharmaceutical field. Background technique [0002] There are 13 kinds of human viral hemorrhagic fever in the world. According to whether the disease has kidney damage, it is divided into two categories: with kidney damage and without kidney damage. In my country, it is mainly hemorrhagic fever with renal syndrome (HFRS), also known as epidemic hemorrhagic fever. Hemorrhagic fever (EHF); called Korean hemorrhagic fever (KHF) in North Korea; called hemorrhagic nephritis nephritis (HNN) in the Soviet Union; due to the establishment of specific serological diagnosis and the resolution of etiology, in 1982, the World Health Organization named it as renal syndrome Symptoms of hemorrhagic fever. [0003] The disease is caused by Korean hemorrhagic fever virus (or Hantaan virus), a natural foci disease with rodents as the main source of infection; it ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/352A61P31/14A61P13/12
Inventor 江春平黄蓉
Owner 李浩福
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com